Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) (Parentheticals) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Statement of Stockholders' Equity [Abstract] | ||||
| Issuance of common stock, net of costs | $ 13,042 | $ 177,420 | ||
| Sale of common stock and pre-funded warrants, net of costs | 75,868 | |||
| Sale of common stock by Citius Oncology, net of costs | $ 2,872,989 | |||
| Direct offering, net of costs | $ 546,782 | |||
| Net of costs | $ 1,770,000 | |||
| Sale of common stock, net of costs | $ 425,949 | |||
| April 2025 registered direct offering, net of costs | 256,116 | |||
| June 2025 registered direct offering, net of costs | $ 571,126 | |||